Background: Although widely adopted, the use of a uterine manipulator during laparoscopic treatment of endometrial cancer represents a debated issue, and some authors hypothesize that it potentially may cause an increased risk of relapse, particularly at specific sites.

Objective: Our aim was to evaluate the risk and site of disease recurrence, overall survival, and disease-specific survival in women who had laparoscopic surgery with and without the use of a uterine manipulator.

Study Design: Data were reviewed from consecutive patients who had laparoscopic surgery for endometrial cancer staging in 7 Italian centers. Subjects were stratified according to whether a uterine manipulator was used during surgery; if so, the type of manipulator was identified. Multivariable analysis to correct for possible confounders and propensity score that matched the minimize selection bias were utilized. The primary outcome was the risk of disease recurrence. Secondary outcomes were disease-specific and overall survival and the site of recurrence, according to the use or no use of the uterine manipulator and to the different types of manipulators used.

Results: We included 951 patients: 579 patients in the manipulator group and 372 patients in the no manipulator group. After a median follow-up period of 46 months (range,12-163 months), the rate of recurrence was 13.5% and 11.6% in the manipulator and no manipulator groups, respectively (P=.37). Positive lymph nodes and myometrial invasion of >50% were associated independently with the risk of recurrence after adjustment for possible confounders. The use of a uterine manipulator did not affect the risk of recurrence, both at univariate (odds ratio, 1.18; 95% confidence interval, 0.80-1.77) and multivariable analysis (odds ratio, 1.00; 95% confidence interval, 0.60-1.70). Disease-free, disease-specific, and overall survivals were similar between groups. Propensity-matched analysis confirmed these findings. The site of recurrence was comparable between groups. In addition, the type of uterine manipulator and the presence or not of a balloon at the tip of the device were not associated significantly with the risk of recurrence.

Conclusion: The use of a uterine manipulator during laparoscopic surgery does not affect the risk of recurrence and has no impact on disease-specific or overall survival and on the site of recurrence in women affected by endometrial cancer.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2017.01.027DOI Listing

Publication Analysis

Top Keywords

uterine manipulator
28
endometrial cancer
16
disease-specific survival
12
laparoscopic surgery
12
site recurrence
12
risk recurrence
12
manipulator
11
recurrence
10
uterine
8
manipulator laparoscopic
8

Similar Publications

MicroRNAs (miRNAs) emerge as critical regulators of CD8 + T cell function within the complex tumor microenvironment (TME). This review explores the multifaceted interplay between miRNAs and CD8 + T cells across various cancers. We discuss how specific miRNAs influence CD8 + T cell activation, recruitment, infiltration, and effector function.

View Article and Find Full Text PDF

Introduction: The three-arm approach is mainly selected, despite the multiple robotic arms in da Vinci Xi. This type of surgical setup may provide less autonomy to the console surgeon and result in greater dependence on the bedside surgical assistant. Therefore, the 4th arm is used instead of the assist port, which is why we developed "pure" robot simple hysterectomy (PRSH) as a novel surgical technique, in which all ports are operated by robotic arms.

View Article and Find Full Text PDF

Oncologic Outcomes of Laparoscopic Radical Hysterectomy Incorporating Modified Tumor-Free Techniques.

Obstet Gynecol

February 2025

National Clinical Research Center for Obstetric & Gynecologic Diseases, Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Article Synopsis
  • The study aimed to determine if modified tumor-free techniques in laparoscopic radical hysterectomy improve outcomes for early-stage cervical cancer patients.
  • Patients who underwent the modified technique had shorter hospital stays and significantly lower recurrence rates compared to those who had conventional surgery.
  • The findings suggest that modified tumor-free laparoscopic hysterectomy is a viable option, leading to better disease-free survival rates in this patient population.
View Article and Find Full Text PDF

Multiple hour antifibrotic drug release enabled by a thermosensitive quadpolymer.

Int J Pharm

January 2025

Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC 27710; Department of Chemistry and Biochemistry, North Carolina Central University, Durham, NC 27707. Electronic address:

Article Synopsis
  • The study focuses on an innovative thermosensitive quadpolymer designed for injection to deliver anti-fibrotic drugs, specifically targeting uterine fibroids while potentially preserving fertility.
  • The quadpolymer functions as an injectable solution at room temperature and transforms into a stable gel at body temperature, allowing for sustained release of the drug pirfenidone.
  • Results showed that the pirfenidone-loaded quadpolymer effectively inhibited fibroid cell proliferation, indicating its potential as a localized treatment option for uterine fibroid therapy.
View Article and Find Full Text PDF

Uterine fibroids are benign tumors, arising from uterine smooth muscle cells. They are one of the most common benign tumors of the female genital tract among childbearing women, occurring in 20%-50% of women of reproductive age. The association of uterine myomas with pregnancy is high.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!